Top Page
Chemring
(LSE:CHG)
Chemring (CHG) vs. iShares MSCI United Kingdom ETF (EWC)
Chemring Business Overview & Revenue Model
Chemring Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 483.90M | 510.40M | 472.60M | 442.80M | 393.30M | 402.50M | Gross Profit |
| 483.90M | 510.40M | 472.60M | 442.80M | 393.30M | 402.50M | EBIT |
| 39.90M | 58.10M | 45.40M | 53.30M | 50.40M | 46.30M | EBITDA |
| 62.40M | 82.70M | 67.10M | 71.20M | 75.50M | 75.10M | Net Income Common Stockholders |
| 3.10M | 39.50M | 5.40M | 47.40M | 41.50M | 34.70M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 19.80M | 45.00M | 6.40M | 19.80M | 5.80M | 14.70M | Total Assets |
| 620.10M | 692.10M | 596.40M | 620.10M | 531.50M | 541.40M | Total Debt |
| 26.90M | 97.70M | 20.70M | 26.90M | 32.30M | 62.80M | Net Debt |
| 7.10M | 52.70M | 14.30M | 7.10M | 26.50M | 48.10M | Total Liabilities |
| 202.00M | 335.80M | 217.90M | 202.00M | 178.70M | 211.80M | Stockholders Equity |
| 418.10M | 356.30M | 378.50M | 418.10M | 352.80M | 329.60M |
| Cash Flow | Free Cash Flow | ||||
| 12.20M | 11.40M | 31.70M | 46.00M | 45.50M | 35.10M | Operating Cash Flow |
| 68.40M | 81.00M | 65.90M | 80.50M | 75.70M | 75.90M | Investing Cash Flow |
| -57.10M | -47.60M | -39.40M | -30.50M | -34.90M | -25.40M | Financing Cash Flow |
| -27.00M | -37.30M | -40.20M | -35.80M | -50.40M | -32.10M |
Chemring Technical Analysis
Chemring Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.38B | 17.97 | 14.44% | 1.92% | 10.36% | 32.77% | |
74 Outperform | £1.17B | 30.01 | 11.62% | 1.80% | 8.00% | 674.47% | |
64 Neutral | $4.46B | 11.94 | 5.17% | 249.36% | 4.00% | -12.35% | |
| $70.79B | 29.17 | 17.85% | 1.74% | ― | ― | ||
78 Outperform | £721.06M | 31.91 | 18.73% | 1.00% | 13.49% | 47.00% | |
71 Outperform | £1.89B | 44.84 | 4.71% | 2.22% | -0.68% | -78.93% | |
70 Outperform | £464.55M | 91.62 | 4.18% | 1.13% | 14.69% | ― |
Chemring Corporate Events
Chemring Group PLC announced its capital structure as of April 30, 2025, consisting of 272,349,319 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their interests in the company.
Chemring Group PLC has repurchased 6,260 of its ordinary shares at a weighted average price of 389.9305 pence per share, as part of a buyback program announced earlier in February 2025. The company plans to cancel these shares, which could potentially enhance shareholder value and reflect confidence in its financial health.
Chemring Group PLC has executed a share buyback, purchasing 18,381 of its ordinary shares at a weighted average price of 387.4813 pence per share. This transaction is part of a previously announced buyback program, and the company plans to cancel the purchased shares, potentially impacting its share capital structure and signaling confidence in its financial position.
Chemring Group PLC has executed a share buyback program, purchasing 20,000 of its ordinary shares at a weighted average price of 380.7649 pence per share. This move, part of a previously announced buyback program, is aimed at canceling the purchased shares, potentially enhancing shareholder value by reducing the number of shares in circulation.
Chemring Group PLC has repurchased 19,983 of its ordinary shares at a weighted average price of 382.3015 pence per share as part of its ongoing buyback program announced in February 2025. The company plans to cancel these shares, a move that could potentially enhance shareholder value by reducing the number of shares outstanding, thereby increasing earnings per share and strengthening its market position.
Chemring Group PLC has repurchased 20,000 of its ordinary shares at a weighted average price of 385.4697 pence per share, as part of its buyback program announced in February 2025. This move to cancel the purchased shares is expected to enhance shareholder value and reflects the company’s commitment to optimizing its capital structure.
Chemring Group PLC announced the repurchase of 17,155 of its ordinary shares at an average price of 380.9460 pence per share as part of a buyback program initiated in February 2025. This move is intended to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.
Chemring Group PLC has executed a share buyback, purchasing 8,610 of its ordinary shares at prices ranging from 388.50 to 390.00 pence per share, with a weighted average price of 389.6781 pence. This transaction is part of a previously announced buyback program, and the company intends to cancel the acquired shares, which could potentially enhance shareholder value by reducing the number of shares outstanding.
Chemring Group PLC has executed a share buyback, purchasing 2,726 of its ordinary shares at a weighted average price of 377.5325 pence per share, with plans to cancel these shares. This move is part of a previously announced buyback program, potentially enhancing shareholder value and optimizing the company’s capital structure.
Chemring Group PLC has announced the repurchase of 40,000 of its ordinary shares at a weighted average price of 370.7997 pence per share, as part of its ongoing buyback program initiated in February 2025. This move is intended to cancel the purchased shares, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
Chemring Group PLC has executed a share buyback, purchasing 38,015 ordinary shares at prices ranging from 368.00 to 378.50 pence per share, with a weighted average of 371.3418 pence. This move is part of a previously announced buyback program and aims to cancel the purchased shares, potentially impacting the company’s share value and signaling confidence in its financial health.
Chemring Group PLC has repurchased 40,000 of its ordinary shares as part of a buyback program announced earlier this year. The shares were purchased at prices ranging from 346.50 to 361.00 pence and will be canceled, potentially impacting the company’s share value and market perception by reducing the number of shares outstanding.
Chemring Group PLC has executed a share buyback program, purchasing 37,582 of its ordinary shares at prices ranging from 360 to 370 pence per share, with a weighted average price of 365.5526 pence. The company intends to cancel these shares, which is part of a previously announced buyback program. This move is likely to impact the company’s share value positively by reducing the number of shares in circulation, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
Chemring Group PLC announced the repurchase of 19,908 of its ordinary shares at prices ranging from 342 to 371 pence per share, with a weighted average of 354.0527 pence. This buyback is part of a previously announced program and the company intends to cancel the purchased shares, potentially enhancing shareholder value and signaling confidence in its financial health.
Chemring Group PLC has executed a share buyback program, purchasing 20,000 of its ordinary shares at prices ranging from 370 to 390 pence per share, with a weighted average price of 377.6649 pence. This move is part of a previously announced buyback program and indicates a strategic effort to optimize capital structure, potentially enhancing shareholder value by reducing the number of outstanding shares.
Schroders Plc has increased its voting rights in Chemring Group PLC to 5.0192%, crossing a significant threshold as of March 28, 2025. This acquisition of voting rights indicates a strategic move by Schroders to strengthen its influence within Chemring, potentially impacting the company’s governance and future strategic decisions.
Chemring Group PLC has executed a share buyback, purchasing 17,965 of its ordinary shares at prices ranging from 386.50 to 390.00 pence per share, with a weighted average price of 388.9422 pence. This move is part of a previously announced buyback program and indicates a strategic effort to manage capital structure, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
Roke, a part of Chemring Group PLC, has secured a significant multi-year contract with the UK Ministry of Defence for missile defence, known as the STORM framework. This £251 million contract positions Roke as a key player in the UK’s missile defence ecosystem, enhancing its role in national defence and security by addressing current and future threats such as ballistic and hypersonic missiles. The contract will bolster Roke’s influence in UK defence decision-making and development of next-generation missile defence capabilities, reinforcing its reputation as a trusted partner in solving complex security challenges.
Chemring Group PLC announced the repurchase of 19,223 of its ordinary shares as part of a buyback program initiated in February 2025. The shares were bought at prices ranging from 369.50 to 380.50 pence and will be canceled, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
Chemring Group PLC has announced its capital structure as of March 31, 2025, which includes 272,731,749 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights, except in specific situations. This disclosure aligns with the FCA’s rules and assists shareholders in determining their notification obligations regarding their interests in the company.
Chemring Group PLC has repurchased 20,000 of its ordinary shares at a weighted average price of 371.3588 pence per share as part of its ongoing buyback program. This move, aimed at canceling the shares, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value.
Schroders Plc has increased its voting rights in Chemring Group PLC to 5.013396% as of March 28, 2025. This acquisition of voting rights may influence Chemring’s strategic decisions and reflects Schroders’ growing interest in the company’s operations, potentially impacting stakeholder dynamics and market perceptions.
Chemring Group PLC has repurchased 20,000 of its ordinary shares as part of a buyback program announced earlier in February 2025. The shares were purchased at prices ranging from 377 to 386 pence, with a weighted average price of 381.6539 pence, and are intended to be canceled. This move is part of Chemring’s strategy to optimize its capital structure and potentially enhance shareholder value.
Chemring Group PLC announced the repurchase of 20,000 of its ordinary shares through Investec Bank plc, with plans to cancel these shares as part of a buyback program initiated in February 2025. This move is likely aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting a strategic effort to strengthen its market position.
Chemring Group PLC has executed a buyback of 20,000 ordinary shares at prices ranging from 373.00 to 377.00 pence per share, with a weighted average price of 374.9252 pence. This transaction is part of a previously announced buyback program, and the company plans to cancel the purchased shares, potentially enhancing shareholder value and optimizing capital structure.
Chemring Group PLC has executed a share buyback program, purchasing 19,151 of its ordinary shares at prices ranging from 371.00 to 379.50 pence, with a weighted average price of 374.7598 pence. The company intends to cancel these shares, a move that may positively impact its share value and demonstrate financial stability, potentially benefiting shareholders by increasing earnings per share.
Chemring Group PLC announced the purchase of 18,593 of its ordinary shares through Investec Bank plc, as part of a buyback program initiated in February 2025. The shares were bought at a weighted average price of 372.8881 pence and are intended to be canceled, a move that could impact the company’s share value and market perception by reducing the number of shares in circulation.
Chemring Group PLC has executed a share buyback program, purchasing 60,000 of its ordinary shares at prices ranging from 372.50 to 384.50 pence per share, with a weighted average price of 377.9359 pence. The company intends to cancel these shares, which is part of a previously announced buyback program, potentially enhancing shareholder value and optimizing capital structure.
Chemring Group PLC announced the repurchase of 59,794 of its ordinary shares at a weighted average price of 388.7913 pence per share as part of its buyback program. The company plans to cancel these shares, a move that could potentially enhance shareholder value by reducing the number of outstanding shares and increasing earnings per share.
Chemring Group PLC announced the purchase of 17,531 of its ordinary shares through Investec Bank plc, with the intention to cancel these shares as part of a buyback program initiated on 26 February 2025. This move is part of Chemring’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting a proactive approach in optimizing its financial operations.
Chemring Group PLC has announced a share buyback, purchasing 59,757 of its ordinary shares at a weighted average price of 387.0634 pence per share. This move is part of a previously announced buyback program and aims to cancel the purchased shares, potentially enhancing shareholder value and optimizing the company’s capital structure.
Chemring Group PLC announced that Sarah Ellard, a director of the company, has sold 27,445 ordinary shares, retaining an interest in 233,000 shares. This transaction is part of the public disclosure requirements for persons discharging managerial responsibilities, reflecting transparency in the company’s operations.
Chemring Group PLC, a company involved in the defense and aerospace industry, has announced the purchase of 20,883 of its ordinary shares through Investec Bank plc, as part of a share buyback program initiated on February 26, 2025. The shares were bought at prices ranging from 380.50 pence to 390.00 pence per share, with a weighted average price of 386.4270 pence. The company plans to cancel the purchased shares, which is a strategic move that may impact its stock value and shareholder equity.
Chemring Group PLC has announced its capital structure as of February 28, 2025, consisting of 273,115,575 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights. This information is crucial for shareholders to determine their reporting requirements under the FCA’s Disclosure and Transparency Rules, impacting how they manage their investments in the company.
Chemring Group PLC has announced the purchase of 58,159 of its ordinary shares through Investec Bank plc, as part of a buyback program initiated on February 26, 2025. The shares were acquired at prices ranging from 371.50 to 380.00 pence, with a weighted average price of 377.3103 pence. The company plans to cancel these shares, which could potentially enhance shareholder value by reducing the number of shares outstanding and improving earnings per share.
Chemring Group PLC has announced the grant of long-term incentive awards to its directors, Michael Ord, James Mortensen, and Sarah Ellard, under the company’s Long Term Incentive Plan. These conditional awards, which involve ordinary shares, are set to vest on December 18, 2027, contingent on continued service and performance conditions. This move, disclosed in the company’s 2024 annual report and approved at the recent Annual General Meeting, reflects Chemring’s commitment to aligning leadership incentives with long-term company performance, potentially impacting its operational focus and stakeholder confidence.
Chemring Group PLC has announced a change in its major holdings, with BlackRock, Inc. increasing its voting rights in the company to 8.17%. This adjustment in holdings reflects a slight increase from the previous 8.15%, indicating BlackRock’s continued interest and investment in Chemring. The change in voting rights could influence future company decisions and strategies, impacting stakeholders and potentially affecting Chemring’s market positioning within the defense and security sector.
Chemring Group PLC, a company involved in the defense and aerospace industry, has announced the repurchase of 4,654 ordinary shares through Investec Bank plc, with the intention to cancel these shares. This move is part of a buyback program announced on February 26, 2025, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value.
Chemring Group PLC announced that all resolutions proposed at its Annual General Meeting on 26 February 2025 were passed with the required majority through a poll vote. This outcome reflects strong shareholder support for the company’s strategic direction and governance, potentially reinforcing its position in the defense and security sector. The resolutions, which included both ordinary and special resolutions, will be submitted to the National Storage Mechanism for public inspection.
Chemring Group PLC announced an optimistic outlook for FY25, with its order book reaching a record £1,351 million, reflecting strong customer demand across its sectors. The company is well-positioned for future growth, supported by significant orders and a new £40 million share buyback program. The Group’s strategic focus on expanding capacity and capability aligns with the increasing market opportunities, particularly in light of heightened NATO defense spending and European defense production coordination. This strategic direction aims to achieve annual revenue of approximately £1 billion by 2030, with mid-teen margins in the medium term.
Chemring Group PLC, a UK-based company, has announced a change in the voting rights held by BlackRock, Inc., a major shareholder. On February 24, 2025, BlackRock’s total voting rights in Chemring decreased from 8.51% to 8.15%, with direct voting rights at 7.04% and indirect rights through financial instruments at 1.11%. This adjustment in BlackRock’s holdings could influence Chemring’s shareholder dynamics and potentially impact its strategic decisions.